Managing Myeloma
- 2011-12-10 - Addition of Bortezomib to Thalidomide-Dexamethasone as Post-ASCT Consolidation Therapy Significantly Increases Response and PFS in Multiple Myeloma -- MPR
- 2011-12-10 - Sarah Cannon Research Institute Presents Findings of Blood Cancer Clinical Trials at National Conference -- Market Watch/Business Wire
- 2011-12-05 - Keryx Biopharmaceuticals Announces Upcoming Presentations on KRX-0401 (Perifosine) at 53rd Annual Meeting of American Society of Hematology -- PR Newswire
- 2011-12-05 - CIBD: Activin A May Be Key in Myeloma Bone Disease -- Medpage Today
- 2011-12-02 - Salvage transplant safe, feasible for multiple myeloma -- Medpage Today
- 2011-11-30 - Breaking News: Multiple Myeloma - First Risk Genes Discovered-- Medical News Today
- 2011-11-29 - Severe Comorbidity Doubles Death Risk in Multiple Myeloma -- Oncology Report Digital Network
- 2011-11-29 - FDA accepts Onyx application for multiple myeloma drug -- San Francisco Business Times
- 2011-11-23 - Celgene’s Lenalidomide Cleared In Sweden -- Daily Markets
- 2011-11-14 - Novel Therapies Put Multiple Myeloma 'On the Ropes' -- The Oncology Report
- 2011-11-14 - Cancer drug Doxorubicin joins growing list of drugs in short supply -- Los Angeles Times
- 2011-11-11 - Celgene a 5-star buy -- MSN Money
- 2011-11-11 - VCU Massey Scientists Defeat Hurdle to Eradicating Inactive Multiple Myeloma Cells -- HealthCanal.com
- 2011-11-10 - Global Multiple Myeloma Therapeutics Market to Reach US$6.4 Billion by 2017, According to a New Report by Global Industry Analysts, Inc. -- PRWeb Press Release
- 2011-11-10 - UAMS Center Treats Its 10,000th Patient -- Times Record